Malta - engleză - Medicines Authority

glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - pertactin, pertussis filamentous, haemagglutinin, pertussis toxoid, poliovirus, inactivated, type, mahoney strain, mef, saukett strain, diphtheria toxoid, haemophilus influenzae, type b, polysaccharide, polyribosylribitol phosphate, tetanus toxoid - powder and suspension for suspension for injection - pertactin 8 µg pertussis filamentous haemagglutinin 25 µg pertussis toxoid 25 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu/0.5ml poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu/0.5ml poliovirus (inactivated) type 3 (saukett strain) 32 dagu/0.5ml diphtheria toxoid haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) 10 µg tetanus toxoid - vaccines

Uniunea Europeană - engleză - EMA (European Medicines Agency)

sanofi pasteur msd, snc - polyribosylribitol phosphate from haemophilus influenzae type b as prp-ompc, outer membrane protein complex of neisseria meningitidis (outer membrane protein complex of the b11 strain of neisseria meningitidis subgroup b), adsorbed hepatitis b surface antigen produced in recombinant yeast cells (saccharomyces cerevisiae) - hepatitis b; meningitis, haemophilus; immunization - vaccines - procomvax is indicated for vaccination against invasive disease caused by haemophilus influenzae type b and against infection caused by all known subtypes of hepatitis b virus in infants 6 weeks to 15 months of age.,

Uniunea Europeană - engleză - EMA (European Medicines Agency)

mcm vaccine b.v. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens: pertussis toxoid, filamentous haemagglutinin, pertactin, fimbriae types 2 and 3, hepatitis b surface antigen produced in yeast cells, poliovirus (inactivated): type 1 (mahoney), type 2 (mef-1), type 3 (saukett) produced in vero cells/ haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to meningococcal protein. - meningitis, haemophilus; poliomyelitis; tetanus; diphtheria; whooping cough; hepatitis b - vaccines - vaxelis (dtap-hb-ipv-hib) is indicated for primary and booster vaccination in infants and toddlers from the age of 6 weeks, against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and invasive diseases caused by haemophilus influenzae type b (hib). the use of vaxelis should be in accordance with official recommendations.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

deseret biologicals, inc. - antimony arsenate (unii: we3458xnft) (arsenate ion - unii:g1dbi405ok), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), camphor (natural) (unii: n20hl7q941) (camphor (natural) - unii:n20hl7q941), activated charcoal (unii: 2p3vwu3h10) (activated charcoal - unii:2p3vwu3h10), chelidonium majus whole (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), quinine hydrochloride (unii: 711s8y0t33) (quinine - unii:a7v27phc7a), copper (unii: 789u1901c5) (copper - unii:789u1901c5), gelsemium sempervirens root (unii: 639kr60q1q) (gelsemium sempervirens root - unii:639kr60q1q), haemophilus influenzae type b (unii: f2tw0n64fi) (haemophilus influenzae type b - unii:f2tw0n64fi), ipecac (unii: 62i3c8233l) (ipecac - unii:62i3c8233l), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), pratia purpurascens (unii: 901nkd188b) (pratia purpurascens - unii:901nkd188b), sus scrofa lung (unii: 7gl3g1cob3) (sus scrofa lung - unii:7gl3g1cob3), mycoplasma pneumoniae (unii: jqe470fad0) (mycoplasma pneumoniae - unii:jqe470fad0), mycoplasma pneumoniae dna (unii: aen1wx7zgr) (mycoplasma pneumoniae dna - unii:aen1wx7zgr), oxygen (unii: s88tt14065) (oxygen - unii:s88tt14065), phosphorus (unii: 27ylu75u4w) (phosphorus - unii:27ylu75u4w), streptococcus pneumoniae (unii: bt6u234yr2) (streptococcus pneumoniae - unii:bt6u234yr2), polygala senega root (unii: m7t6h7d4if) (polygala senega root - unii:m7t6h7d4if), tin (unii: 387gmg9fh5) (tin - unii:387gmg9fh5), veratrum viride root (unii: 197b3q7t5q) (veratrum viride root - unii:197b3q7t5q) - antimonium arsenicicum - cough, bryonia (alba) – lung support, camphora - fatigue, carbo vegetabilis - cough, chelidonium majus - fatigue, chininum muriaticum - cough, cuprum metallicum – lung support, gelsemium sempervirens - fatigue, haemophilus influenzae - cough, ipecacuanha – lung support, kali muriaticum - fatigue, lobelia purpurescens - cough, lung (suis) – lung support, mycoplasma pneumoniae - fatigue, mycoplasma pneumoniae dna - fatigue, oxygenium - cough, phosphorus – lung support, pneumococcinum - fatigue, senega officinalis - cough, stannum metallicum – lung support, veratrum viride - fatigue • for the temporary relief of symptoms including: • fatigue • cough • lung support these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - conjugate of haemophilus influenzae type b capsular polysaccharide (polyribosylribitol phosphate) and tetanus; conjugate of neisseria meningitides c capsular polysaccharide and tetanus toxoid (mean tt/ps ratio :1) - powder and solvent for solution for injection - 0.5 millilitre(s) - hemophilus influenzae b, combinations with meningococcus c, conjugated

Namibia - engleză - Namibia Medicines Regulatory Council

serum institute of india ltd - diphtheria, tetanus, ; pertussis, hepatitis b; haemophilus influenzae type b conjugate - injection - each dose of 0.5 ml contains diphtheria ; toxoid ? 30 iu, tetanus toxoid ? 40 iu, ; haemophilus influenzae type b.pertussis

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - haemophilus influenzae type b prp 5ug (conjugated with 12.5 mcg tetanus toxoid);  ; neisseria meningitidis group c polysaccharide 5ug (5 mcg men c polysaccharide conjugated to 5 mcg tetanus toxoid) - injection with diluent - 0.5 ml - active: haemophilus influenzae type b prp 5ug (conjugated with 12.5 mcg tetanus toxoid)   neisseria meningitidis group c polysaccharide 5ug (5 mcg men c polysaccharide conjugated to 5 mcg tetanus toxoid) excipient: sodium chloride sucrose tetanus toxoid trometamol hydrochloride sodium chloride water for injection - menitorix is indicated for the prevention of invasive diseases caused by haemophilus influenzae type b (hib) and neisseria meningitidis serogroup c (menc).

Israel - engleză - Ministry of Health

sanofi israel ltd - conjugated to tetanus protein; diphtheria toxoid; filamentous haemagglutinin (fha); haemophilus influenzae type b polysaccharide; pertussis toxoid (pt); polio type i (mohoney); polio type ii ( m.e.f.1); polio type iii (saukett); tetanus toxoid - powder and suspension for suspension for injection - polio type iii (saukett) 32 du / 0.5 ml; polio type ii ( m.e.f.1) 8 du / 0.5 ml; polio type i (mohoney) 40 du / 0.5 ml; filamentous haemagglutinin (fha) 25 mcg / 0.5 ml; pertussis toxoid (pt) 25 mcg / 0.5 ml; tetanus toxoid 40 iu / 0.5 ml; diphtheria toxoid 30 iu / 0.5 ml; haemophilus influenzae type b polysaccharide 10 mcg / 0.5 ml; conjugated to tetanus protein 18-30 mcg / 0.5 ml - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - active immunisation against diphtheria, tetanus, pertussis, poliomyelitis and invasive infections caused by haemophilus influenzae type b (meningitis, septicaemia, cellulitis, arthritis, epiglottitis, …)• for primary vaccination in infants.• for booster in children who have previously received a primary vaccination with this vaccine or a diphtheria-tetanus-whole-cell or acellular pertussis poliomyelitis vaccine, whether mixed or not with freeze-dried conjugate haemophilus influenzae type b vaccine.

Israel - engleză - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; fillamentous haemagglutinin (fha); haemophilus influenzae type b polysaccharide; inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin; pertussis toxoid (pt); tetanus toxoid - powder and suspension for suspension for injection - diphtheria toxoid nlt 60 iu/ml; inactivated polio virus (ipv) type 3 64 du / 1 ml; inactivated polio virus (ipv) type 2 16 du / 1 ml; inactivated polio virus (ipv) type 1 80 du / 1 ml; pertussis toxoid (pt) 50 mcg/ml; fillamentous haemagglutinin (fha) 50 mcg/ml; pertactin 16 mcg/ml; tetanus toxoid nlt 80 iu/ml; haemophilus influenzae type b polysaccharide 20 mcg/vial - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - active immunisation in infants from the age of 2 months to 5 years against diptheria, tetanus, pertussis, poliomyelitis and haemophilus influenza type b. booster dose for children who have previously been immunised with dtp, polio and hib antigens

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - haemophilus influenzae type b, conjugate with tetanus protein - pdr+solv for soln for inj - 10mcg/0.5m microgram/ml - hemophilus influenzae b vaccines